4//SEC Filing
Wessels Gregory S. 4
Accession 0000905148-20-001030
CIK 0001781983other
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 5:05 PM ET
Size
5.0 KB
Accession
0000905148-20-001030
Insider Transaction Report
Form 4
Wessels Gregory S.
SVP, Chief Commercial Officer
Transactions
- Award
Stock Option (right to Buy)
2020-09-16+14,700→ 14,700 totalExercise: $28.75Exp: 2030-09-16→ Common Stock (14,700 underlying)
Footnotes (1)
- [F1]Twenty-five percent of these options vest on September 16, 2021, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting date and subject to acceleration under certain conditions.
Documents
Issuer
Aprea Therapeutics, Inc.
CIK 0001781983
Entity typeother
Related Parties
1- filerCIK 0001824615
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 5:05 PM ET
- Size
- 5.0 KB